Comparative Pharmacology
Head-to-head clinical analysis: ESTINYL versus LEVONORGESTREL AND ETHINYL ESTRADIOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ESTINYL versus LEVONORGESTREL AND ETHINYL ESTRADIOL.
ESTINYL vs LEVONORGESTREL AND ETHINYL ESTRADIOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Estinyl (ethinyl estradiol) is a synthetic estrogen that binds to estrogen receptors, leading to increased synthesis of DNA, RNA, and various proteins in target tissues. It suppresses gonadotropin release, modulating the hypothalamic-pituitary-ovarian axis.
Levonorgestrel is a progestin that suppresses gonadotropin release, inhibiting ovulation; ethinyl estradiol is an estrogen that stabilizes the endometrium and provides feedback inhibition on the hypothalamic-pituitary-ovarian axis, preventing follicular development and ovulation.
0.01-0.05 mg orally once daily for contraception or 2.5-10 mg orally 3-4 times daily for 5-10 days for hemostasis in dysfunctional uterine bleeding. Route: oral. Frequency: daily for contraception; multiple daily doses for acute bleeding.
Oral, 1 tablet daily containing 0.1 mg levonorgestrel and 0.02 mg ethinyl estradiol, or 0.15 mg levonorgestrel and 0.03 mg ethinyl estradiol, taken at the same time each day for 21 days followed by 7 placebo tablets, or continuous daily dosing as per product labeling.
None Documented
None Documented
Terminal elimination half-life is approximately 13-27 hours (mean ~17 hours); enterohepatic recirculation contributes to variability; steady-state achieved within 3-5 days.
Levonorgestrel: terminal half-life approximately 24-32 hours. Ethinyl estradiol: terminal half-life approximately 13-27 hours (mean ~17 hours). The half-lives are relevant for once-daily dosing, achieving steady state within 5-7 days.
Renal excretion of metabolites (approximately 40-50% as ethinyl estradiol glucuronide and sulfate conjugates) and fecal excretion (approximately 20-30% as conjugates and minor metabolites); <10% excreted unchanged in urine.
Levonorgestrel and ethinyl estradiol are primarily eliminated via renal excretion (40-68% as metabolites) and fecal excretion (20-45%). Less than 1% is excreted unchanged.
Category C
Category D/X
Estrogen
Estrogen